Vicplas International Ltd (SGX: 569)
Health Care · Health Care Equipment & Supplies · SG
S$0.07
-17.65% today · -16.7% 1Y
Vicplas International Ltd (SGX: 569) operates in the Health Care Equipment & Supplies industry within the Health Care sector. The company is valued at $28.18M and employs 702 people.
Over the last twelve months the share price has lost 16.7%, trading between 0.07 and 0.10.
Tweenvest scores Vicplas International Ltd across four factors: quality 63/100, value 72/100, growth 37/100. Its strongest factor is value.
569 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $28.18M
- Revenue (TTM)
- $100.86M
- P/E
- —
- EPS
- -0.01
- Dividend yield
- —
- Beta (5Y)
- 0.25
- 52-week high
- S$0.10
- 52-week low
- S$0.07
- Avg volume (3M)
- —
- Shares outstanding
- 511.08M
- Employees
- 702
- Next earnings
- —
About Vicplas International Ltd
Vicplas International Ltd, established in Singapore in 1993, operates as an investment holding company with key business segments in medical devices and piping systems. The company's geographical reach includes Singapore, Malaysia, the People's Republic of China, and the United Kingdom. Its piping division focuses on the manufacturing, trading, and distribution of a variety of piping solutions. These systems are utilized for diverse applications such as waste and potable water management in residential, educational, commercial, and industrial settings; conduits for underground electrical and internal building wiring; and data and signal lines for telecommunication providers. Additionally, Vicplas is engaged in the design, development, production, and assembly of both sterile and non-sterile medical devices. The company also offers specialized project design and engineering services. Vicplas International Ltd is a subsidiary of Venner Capital S.A.
- ISIN
- SG1G57870584
- Founded
- 1993
- Listed since
- Jan 3, 2000
- Exchange
- Singapore Exchange
- Currency
- SGD
Other Health Care Equipment & Supplies companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Abbott LaboratoriesNYSE: ABT | $200.95B | $115.82 | -0.27% |
| Intuitive Surgical, Inc.NasdaqGS: ISRG | $131.36B | $371.72 | -0.03% |
| Stryker CorporationNYSE: SYK | $126.81B | $332.00 | +0.43% |
| Medtronic plcNYSE: MDT | $116.66B | $91.23 | +0.10% |
| EssilorLuxottica Société anonymeENXTPA: EL | $85.36B | €160.65 | +0.94% |
| Boston Scientific CorporationNYSE: BSX | $72.26B | $47.14 | -5.46% |
| HOYA CorporationTSE: 7741 | $52.49B | ¥24,995.00 | +0.40% |
| Edwards Lifesciences CorporationNYSE: EW | $52.38B | $90.87 | +0.41% |
Figures last refreshed Aug 18, 2026.